HIV/AIDS lessons helping B.C. tackle opioid epidemic

The opioid crisis continues to be one of B.C.’s most pressing health issues and now as Aaron McArthur reports, experts who were on the frontlines of the HIV/AIDS epidemic are using their knowledge to help stem the tide of overdose deaths.Today’s Global News Hour at 6 Health Matters is brought to you by Pharmasave.

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025